2013 update on the worldwide standardization of the HbA1c measurement

Diabetic Medicine

Volumn 30, Issue 7, 2013, Pages 885-886

  Hanas, R ^a,b   John, W G ^c  

^a UDDEVALLA HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

FOLLOW UP; GOLD STANDARD; INTERNATIONAL STANDARD UNIT; LABORATORY DEVICE; LETTER; PROTEIN BLOOD LEVEL; STANDARDIZATION;

CLINICAL CHEMISTRY TESTS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; REFERENCE VALUES;

EID: 84879603154     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12204     Document Type: Letter

References (5)

1. Diabetes Control and Complications Trial. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
3. Hoelzel W, Weykamp C, Jeppsson JO, Miedema K, Barr JR, Goodall I et al. IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan and Sweden: a method-comparison study. Clin Chem 2004; 50: 166-174.
4. Consensus statement on the worldwide standardisation of the HbA1c measurement. Diabetologia 2007; 50: 2042-2043.
5. 1c measurement. Diabet Med 2010; 27: 737-738.